Get started
Author

J L Valero Sanz

Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT
2026 · Annalisa Paviglianiti, Maud Ngoya, et al. · Bone Marrow Transplantation · 2
The 2026 definition of ruxolitinib refractoriness in severe acute GVHD
2026 · Florent Malard, Yi Bin Chen, et al. · Bone Marrow Transplantation · 1
Secondary Malignancies After Hematopoietic Stem Cell Transplantation
2026 · Pedro Asensi Cantó, Miguel Mansilla-Polo, et al. · Transplantation and Cellular Therapy · 1
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP)
2026 · Fabio Andreozzi, Jacques-Emmanuel Galimard, et al. · Bone Marrow Transplantation · 1
Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party
2026 · Gesine Bug, Myriam Labopin, et al. · Bone Marrow Transplantation · 1
PDF
Impact of ASTCT Toxicity Grading System on Outcomes After CAR-T for Mature B-Cell Malignancies
2026 · Marina Gomez-Llobell, Silvia Escribano Serrat, et al. · Transplantation and Cellular Therapy
Treosulfan/fludarabine versus thiotepa/busulfan/fludarabine for allogeneic haematopoietic cell transplantation in lymphoma in the post‐transplant cyclophosphamide era: A GETH ‐ TC study
2026 · Marta Peña, Lorenzo Lazzari, et al. · British Journal of Haematology
PDF
The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations
2025 · Iman Abou Dalle, Jacques-Emmanuel Galimard, et al. · Bone Marrow Transplantation
Enfermedad Linfoproliferativa Post- Trasplante de Progenitores Hematopoyéticos (SLPT): Aspectos Clínicos
2013 · J L Valero Sanz
Works count: 9
Citation count: 6
H-index: 1
I10-index:
Year
Topic
Type